Page last updated: 2024-10-27

fluorouracil and Chronic Pancreatitis

fluorouracil has been researched along with Chronic Pancreatitis in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"Chronic pancreatitis is characterized by chronic inflammation and fibrosis, processes heightened by activated pancreatic stellate cells (PSCs)."1.915-FU-miR-15a Inhibits Activation of Pancreatic Stellate Cells by Reducing YAP1 and BCL-2 Levels In Vitro. ( Almanzar, VMD; Bialkowska, AB; Cheung, J; Ju, J; LaComb, JF; Mojumdar, A; Patel, HR; Shah, K; Tang, M, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Almanzar, VMD1
Shah, K1
LaComb, JF1
Mojumdar, A1
Patel, HR1
Cheung, J1
Tang, M1
Ju, J1
Bialkowska, AB1
Gurzu, S1
Jung, I1
Comsulea, M1
Kadar, Z1
Azamfirei, L1
Molnar, C1

Other Studies

2 other studies available for fluorouracil and Chronic Pancreatitis

ArticleYear
5-FU-miR-15a Inhibits Activation of Pancreatic Stellate Cells by Reducing YAP1 and BCL-2 Levels In Vitro.
    International journal of molecular sciences, 2023, Feb-16, Volume: 24, Issue:4

    Topics: Animals; Cell Proliferation; Fibrosis; Fluorouracil; Mice; MicroRNAs; Pancreatic Stellate Cells; Pan

2023
Lethal cardiotoxicity, steatohepatitis, chronic pancreatitis, and acute enteritis induced by capecitabine and oxaliplatin in a 36-year-old woman.
    Diagnostic pathology, 2013, Sep-16, Volume: 8

    Topics: Acute Disease; Adenocarcinoma; Adult; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protoco

2013